9-137234125-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001177316.2(SLC34A3):c.942G>C(p.Ala314Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0105 in 1,588,666 control chromosomes in the GnomAD database, including 285 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0090 ( 18 hom., cov: 31)
Exomes 𝑓: 0.011 ( 267 hom. )
Consequence
SLC34A3
NM_001177316.2 synonymous
NM_001177316.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.52
Publications
3 publications found
Genes affected
SLC34A3 (HGNC:20305): (solute carrier family 34 member 3) This gene encodes a member of SLC34A transporter family of proteins, and is expressed primarily in the kidney. It is involved in transporting phosphate into cells via sodium cotransport in the renal brush border membrane, and contributes to the maintenance of inorganic phosphate concentration in the kidney. Mutations in this gene are associated with hereditary hypophosphatemic rickets with hypercalciuria. Alternatively spliced transcript variants varying in the 5' UTR have been found for this gene.[provided by RefSeq, Apr 2010]
SLC34A3 Gene-Disease associations (from GenCC):
- hereditary hypophosphatemic rickets with hypercalciuriaInheritance: SD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 9-137234125-G-C is Benign according to our data. Variant chr9-137234125-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1169030.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.52 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0507 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC34A3 | ENST00000673835.1 | c.942G>C | p.Ala314Ala | synonymous_variant | Exon 10 of 13 | NM_001177316.2 | ENSP00000501114.1 | |||
| SLC34A3 | ENST00000361134.2 | c.942G>C | p.Ala314Ala | synonymous_variant | Exon 10 of 13 | 2 | ENSP00000355353.2 | |||
| SLC34A3 | ENST00000538474.5 | c.942G>C | p.Ala314Ala | synonymous_variant | Exon 10 of 13 | 5 | ENSP00000442397.1 | |||
| SLC34A3 | ENST00000673865.1 | c.942G>C | p.Ala314Ala | synonymous_variant | Exon 10 of 10 | ENSP00000501101.1 |
Frequencies
GnomAD3 genomes AF: 0.00902 AC: 1353AN: 150056Hom.: 18 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1353
AN:
150056
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0160 AC: 3500AN: 218422 AF XY: 0.0178 show subpopulations
GnomAD2 exomes
AF:
AC:
3500
AN:
218422
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0106 AC: 15272AN: 1438494Hom.: 267 Cov.: 35 AF XY: 0.0120 AC XY: 8588AN XY: 715010 show subpopulations
GnomAD4 exome
AF:
AC:
15272
AN:
1438494
Hom.:
Cov.:
35
AF XY:
AC XY:
8588
AN XY:
715010
show subpopulations
African (AFR)
AF:
AC:
65
AN:
33312
American (AMR)
AF:
AC:
184
AN:
43746
Ashkenazi Jewish (ASJ)
AF:
AC:
928
AN:
25886
East Asian (EAS)
AF:
AC:
1763
AN:
39140
South Asian (SAS)
AF:
AC:
4280
AN:
84558
European-Finnish (FIN)
AF:
AC:
347
AN:
39918
Middle Eastern (MID)
AF:
AC:
189
AN:
4922
European-Non Finnish (NFE)
AF:
AC:
6593
AN:
1107274
Other (OTH)
AF:
AC:
923
AN:
59738
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
912
1824
2737
3649
4561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00902 AC: 1354AN: 150172Hom.: 18 Cov.: 31 AF XY: 0.00980 AC XY: 718AN XY: 73242 show subpopulations
GnomAD4 genome
AF:
AC:
1354
AN:
150172
Hom.:
Cov.:
31
AF XY:
AC XY:
718
AN XY:
73242
show subpopulations
African (AFR)
AF:
AC:
91
AN:
40620
American (AMR)
AF:
AC:
58
AN:
15098
Ashkenazi Jewish (ASJ)
AF:
AC:
128
AN:
3470
East Asian (EAS)
AF:
AC:
283
AN:
5046
South Asian (SAS)
AF:
AC:
217
AN:
4740
European-Finnish (FIN)
AF:
AC:
61
AN:
10270
Middle Eastern (MID)
AF:
AC:
5
AN:
292
European-Non Finnish (NFE)
AF:
AC:
473
AN:
67652
Other (OTH)
AF:
AC:
20
AN:
2076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
55
110
164
219
274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
154
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 29, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive hypophosphatemic bone disease Benign:2
Jul 27, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.